Safety of Eslicarbazepine Acetate in Elderly Versus Non-Elderly Patients with Focal Seizures: From Pooled Data of Clinical Studies to 8 Years of Post-Marketing Experience.
Luís M MagalhãesRaquel CostaMariana VieiraJoana MoreiraHelena GamaPatricio Soares-Da-SilvaPublished in: Drug safety (2021)
No specific safety issue was identified from the pooled studies for elderly compared with non-elderly patients. After 8 years of post-marketing surveillance, the qualitative safety of ESL remains similar to that observed in the clinical studies.